In today’s briefing:
- Argosy Investors Q1 2022 Letter
- Harding Loevner Global Equity Fund Q1 2022 Letter
Argosy Investors Q1 2022 Letter
- Argosy Investors is a fee-only investment adviser seeking to earn above-average returns through a risk-conscious approach that allows us to maintain significant amounts of cash if the conditions warrant, and to deploy capital quickly and aggressively when opportunities are more plentiful.
- 2022 first quarter performance was -15.1% in select accounts.
- Analyzing many businesses can be challenging, and could require a greater degree of conservatism in assessing likely sales and/or margin potential.
Harding Loevner Global Equity Fund Q1 2022 Letter
- Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989.
- Stock markets fell in the quarter, as the world watched in horror Russia’s invasion of Ukraine.
- China-based WuXi Biologics illustrates the perfect storm of macro issues pressuring the share prices of our rapidly growing companies.
- As questions mount whether globalization has reached a tipping point, companies are taking full advantage of the many advances occurring across the industrial automation landscape— propelling leadingp roviders of “Industry 4.0” solutions onto favorable growth paths.
Before it’s here, it’s on Smartkarma
